Evidence map›Paper›PMID 32833478›Full record

ArticleHealth psychology : official journal of the Division of Health Psychology, American Psychological Association2020

The positive affect, promoting Positive Engagement, and Adherence for Life (APPEAL) feasibility trial: Design and rationale.

Tracey E Wilson, Chanée Massiah, Rachel Radigan, Jack DeHovitz, Usha S Govindarajulu, Susan Holman, Michelle Melendez, Jameela Yusuff, Tonya Taylor

Abstract read
In one paragraph

Article in Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. AIDS patient care and STDs · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tracey E WilsonDepartment of Community Health Sciences and Medicine, State University of New York, Downstate Health Sciences University.ORCID 0000-0002-2087-8545
Chanée MassiahDepartment of Epidemiology and Biostatistics, State University of New York, Downstate Health Sciences University.
Rachel RadiganDepartment of Epidemiology and Biostatistics, State University of New York, Downstate Health Sciences University.
Jack DeHovitzDepartment of Medicine, State University of New York, Downstate Health Sciences University.
Usha S GovindarajuluDepartment of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai.
Susan HolmanDepartment of Medicine, State University of New York, Downstate Health Sciences University.
Michelle MelendezDepartment of Medicine, State University of New York, Downstate Health Sciences University.
Jameela YusuffDepartment of Medicine, State University of New York, Downstate Health Sciences University.
Tonya TaylorDepartment of Medicine, State University of New York, Downstate Health Sciences University.

Funding

Positive affect promotion to empower optimal adherence to HIV therapyR21NR018348 · NINR · SUNY DOWNSTATE MEDICAL CENTER · PI WILSON, TRACEY ELIZABETH · 2018 to 2019
$444k
National Institutes of Health; Science of Behavior Change Common Fund ProgramNINR NIH HHS R21 NR018348
6 · The paper itself

Abstract

objectiveTo describe development of the Positive Affect, Promoting Positive Engagement, and Adherence for Life (APPEAL) program.

methodAPPEAL is intended to increase HIV medication adherence through promotion of positive affect, and was developed through an iterative process involving 6 focus groups (N = 34) that elicited feedback on intervention content, followed by an individually administered prepilot of the entire intervention (N = 7).

resultsParticipants provided feedback on important potential moderator variables, including depression, on mode of intervention administration, and on anticipated barriers and benefits to participation. Insights gained were used to finalize study procedures in preparation for a feasibility trial. For the feasibility trial, a total of 80 participants who, in the past 6 months have had at least one plasma HIV RNA >200 copies/mL, will be randomized to receive APPEAL or standard of care (N = 40 per group). Intervention group participants will receive 3 monthly, individually administered sessions, and all participants will have their medication adherence monitored and complete structured interviews at baseline and at 3 and 6 months.

conclusionThe APPEAL program is innovative in that it focuses on promoting self-regulation of positive emotions, an understudied approach to promoting chronic disease self-management behaviors such as HIV medication adherence. Findings from the feasibility trial will gauge suitability of the APPEAL intervention and evaluation methods for subsequent testing in a confirmatory trial and will examine changes in positive affect, the primary mechanism of change targeted in the intervention. (PsycInfo Database Record (c) 2020 APA, all rights reserved).

Indexed as

Drug MonitoringAdultFeasibility StudiesFemaleFocus GroupsHumansMaleYoung Adult

Identifiers

PMID32833478
PMCPMC7476401

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.